THC Therapeutics Announces $3M Acquisition of SugarTop Buddery

THC Therapeutics, Inc., a company focused on the legal cannabis market, has broadened its operations in Oregon by acquiring STHoldings Group LLC, the parent company of SugarTop Buddery, in a transaction valued at $3 million. The acquisition was completed via the issuance of Series D Preferred stock, marking the company's second strategic acquisition in its ongoing roll-up strategy. This acquisition allows THCT to deepen its operational presence in Oregon and gain ownership of a respected craft cannabis brand with aspirations to expand nationally and internationally. Founded in 2015, SugarTop Buddery has established itself as a community-driven brand with a focus on music, artistry, equity, and sustainability under the leadership of co-founder and CEO Anna Kaplan. The deal extends the reach of SugarTop's unique brand and products, with ambitions to broaden across new markets. The transaction also bolsters THCT's strategy to create a vertically integrated national cannabis platform through targeted acquisitions of market-leading brands.